679 related articles for article (PubMed ID: 16914507)
1. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
2. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
3. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
4. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
5. Homeostasis of V alpha 14i NKT cells.
Matsuda JL; Gapin L; Sidobre S; Kieper WC; Tan JT; Ceredig R; Surh CD; Kronenberg M
Nat Immunol; 2002 Oct; 3(10):966-74. PubMed ID: 12244311
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
7. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
9. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
10. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
[TBL] [Abstract][Full Text] [Related]
11. Regulation of secondary antigen-specific CD8(+) T-cell responses by natural killer T cells.
Hong C; Lee H; Park YK; Shin J; Jung S; Kim H; Hong S; Park SH
Cancer Res; 2009 May; 69(10):4301-8. PubMed ID: 19401453
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
[TBL] [Abstract][Full Text] [Related]
13. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
[TBL] [Abstract][Full Text] [Related]
14. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
15. Role of γδ T cells in α-galactosylceramide-mediated immunity.
Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
[TBL] [Abstract][Full Text] [Related]
16. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
[TBL] [Abstract][Full Text] [Related]
17. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
[TBL] [Abstract][Full Text] [Related]
18. NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production.
Loza MJ; Metelitsa LS; Perussia B
Eur J Immunol; 2002 Dec; 32(12):3453-62. PubMed ID: 12442327
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
20. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
